Research - Oxford, England, United Kingdom
The Oncology drug discovery company of the University of Oxford |Novel targets | First and best-in-class | Precision therapeuticsMatching pioneering Oxford science with world class drug discovery capabilities of the industry. A starting portfolio of four innovative programmes. Financed by OSE (Oxford Science Enterprise), BMS and Evotec. Supported by the University of Oxford and its academics.